Main competitors
Consensus Analysts' target price evolution (4 months) Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Average Target P. Objective/dr gap Nbr of analysts
141.67 +27.17% 15
2,140.91 -18.32% 11
84.89 +26.55% 9
144,142.86 +47.69% 14
144,157.89 +53.69% 19
63.17 +22.65% 6
- 44.58 +1.07% 1
- - - - -
- - 75,000 +43.13% 1
5,366.67 +12.51% 6
3.837 +7.17% 3
- - 32 +80.08% 1
Average 33,743.5 +27.58% 8
Weighted average by Cap. 16,676.08 +24.89% 13
Specialty & Advanced Pharmaceuticals